Active Motif's RVX-208 is a potent BET bromodomain antagonist with (IC50 = 0.51 uM for BD2) with approximately 170-fold selectivity over BD1 (ref 1,2). It increases apolipoprotein A-1 and HDL cholesterol in vitro and in vivo, and it reduces atherosclerosis.